Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 154.37 Million EUR | 0.64% |
| 2022 | 153.4 Million EUR | -7.26% |
| 2021 | 165.41 Million EUR | -7.4% |
| 2020 | 178.62 Million EUR | 7.97% |
| 2019 | 165.44 Million EUR | 29.35% |
| 2018 | 127.9 Million EUR | 17.9% |
| 2017 | 108.48 Million EUR | -2.27% |
| 2016 | 111 Million EUR | -6.92% |
| 2015 | 119.24 Million EUR | -2.63% |
| 2014 | 122.46 Million EUR | 0.5% |
| 2013 | 121.86 Million EUR | -7.34% |
| 2012 | 131.52 Million EUR | 1.57% |
| 2011 | 129.48 Million EUR | -1.38% |
| 2010 | 131.29 Million EUR | 2.1% |
| 2009 | 128.59 Million EUR | -2.7% |
| 2008 | 132.15 Million EUR | 1.24% |
| 2007 | 130.54 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 150.58 Million EUR | 0.0% |
| 2023 Q2 | 155.76 Million EUR | 0.0% |
| 2023 Q3 | 154.37 Million EUR | -0.89% |
| 2023 FY | 154.37 Million EUR | 0.64% |
| 2023 Q4 | 154.37 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q4 | 153.4 Million EUR | 0.0% |
| 2022 Q3 | 153.4 Million EUR | -4.97% |
| 2022 Q2 | 161.41 Million EUR | 0.0% |
| 2022 FY | 153.4 Million EUR | -7.26% |
| 2021 Q4 | 165.41 Million EUR | 0.0% |
| 2021 Q3 | 165.41 Million EUR | -7.68% |
| 2021 FY | 165.41 Million EUR | -7.4% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 179.16 Million EUR | 0.0% |
| 2020 Q3 | 178.62 Million EUR | 2.18% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 174.81 Million EUR | 0.0% |
| 2020 FY | 178.62 Million EUR | 7.97% |
| 2020 Q4 | 178.62 Million EUR | 0.0% |
| 2019 Q3 | 165.44 Million EUR | -1.59% |
| 2019 FY | 165.44 Million EUR | 29.35% |
| 2019 Q2 | 168.11 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q4 | 165.44 Million EUR | 0.0% |
| 2018 Q4 | 127.9 Million EUR | 0.0% |
| 2018 Q3 | 127.9 Million EUR | 21.19% |
| 2018 Q2 | 105.54 Million EUR | 0.0% |
| 2018 FY | 127.9 Million EUR | 17.9% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q3 | 108.48 Million EUR | 0.94% |
| 2017 Q4 | 108.48 Million EUR | 0.0% |
| 2017 Q2 | 107.47 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 FY | 108.48 Million EUR | -2.27% |
| 2016 Q4 | 111 Million EUR | 0.0% |
| 2016 FY | 111 Million EUR | -6.92% |
| 2016 Q3 | 111 Million EUR | -5.26% |
| 2016 Q2 | 117.15 Million EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2015 Q2 | 122.99 Million EUR | 3.09% |
| 2015 Q3 | 120.49 Million EUR | -2.03% |
| 2015 Q4 | 119.24 Million EUR | -1.03% |
| 2015 FY | 119.24 Million EUR | -2.63% |
| 2015 Q1 | 119.3 Million EUR | -2.58% |
| 2014 Q4 | 122.46 Million EUR | 2.57% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 FY | 122.46 Million EUR | 0.5% |
| 2014 Q2 | 118.87 Million EUR | 0.0% |
| 2014 Q3 | 119.39 Million EUR | 0.44% |
| 2013 Q3 | 121.88 Million EUR | -1.14% |
| 2013 FY | 121.86 Million EUR | -7.34% |
| 2013 Q2 | 123.29 Million EUR | -2.99% |
| 2013 Q1 | 127.09 Million EUR | -3.37% |
| 2013 Q4 | 121.86 Million EUR | -0.02% |
| 2012 Q2 | 127.49 Million EUR | -1.44% |
| 2012 Q1 | 129.35 Million EUR | -0.1% |
| 2012 FY | 131.52 Million EUR | 1.57% |
| 2012 Q4 | 131.52 Million EUR | 4.35% |
| 2012 Q3 | 126.03 Million EUR | -1.14% |
| 2011 FY | 129.48 Million EUR | -1.38% |
| 2011 Q3 | 128.12 Million EUR | 0.83% |
| 2011 Q2 | 127.06 Million EUR | -1.41% |
| 2011 Q4 | 129.48 Million EUR | 1.07% |
| 2011 Q1 | 128.87 Million EUR | -1.84% |
| 2010 Q4 | 131.29 Million EUR | 0.0% |
| 2010 FY | 131.29 Million EUR | 2.1% |
| 2009 FY | 128.59 Million EUR | -2.7% |
| 2008 FY | 132.15 Million EUR | 1.24% |
| 2007 FY | 130.54 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 33.92 Billion EUR | 99.545% |
| Fresenius SE & Co. KGaA | 45.28 Billion EUR | 99.659% |
| LIMES Schlosskliniken AG | 33.24 Million EUR | -364.321% |
| M1 Kliniken AG | 212.95 Million EUR | 27.506% |
| MEDICLIN Aktiengesellschaft | 938.6 Million EUR | 83.552% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.77 Billion EUR | 91.324% |
| VITA 34 AG | 158.35 Million EUR | 2.512% |